Potentiation of Prostate Cancer Radiotherapy Using Antiangiogenic and Antitumor Therapies

Abstract

The focus of this grant was to gauge the pathophysiological effects of combinations of radiotherapy and a variety of antiangiogenic agents by studying corresponding changes in vascular maturity and function in PC-3 and DU145 human prostate xenografts. Perfusion, apoptosis, proliferation, and hypoxia indices as well as pericyte and basement membrane coverage were quantified using image analysis of immunohistochemically stained frozen tumor sections. Results argue against a treatment-induced functional normalization of the tumor vasculature following combination therapy. Rather than tightening pericytes, combination treatments loosened pericyte-vessel and pericytebasement membrane associations. Despite reductions in oxygenation and vessel densities, tumor progression was minimal during extended combination treatment, most likely due to continued vascular destruction and the prevention of new vessel growth. Surprisingly, alternative scheduling of antiangiogenic drugs and radiation had minimal effects on tumor progression or pathophysiology.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2007
Accession Number
ADA477949

Entities

People

  • Bruce M. Fenton

Organizations

  • University of Rochester

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Apoptosis
  • Basements
  • Blood
  • Blood Flow
  • Blood Vessels
  • Combination Therapy
  • Endothelial Cells
  • Growth Factors
  • Medical Personnel
  • Membranes
  • Neoplasms
  • Peptides
  • Prostate
  • Radiation
  • Radiotherapy
  • Scheduling (Production)
  • Therapy

Fields of Study

  • Medicine

Readers

  • Oncology (Cancer Research).
  • Oncology and Biomarker-Based Cancer Detection.